Aug 18, 2017 Last Updated 2:35 PM, Aug 17, 2017

New Entry From the Editor :

Telstra cuts dividend outlook after disappointing FY performance

Telstra cuts dividend outlook …

AusBN - Telstra (ASX:TLS) has revealed its full-year (FY) profit dropped 33...

Contrasting fortunes for Origin and Woodside in FY results

Contrasting fortunes for Origi…

AusBN - Origin Energy has posted a full-year (FY) loss of AUS$2.2 billion a...

Report finds majority of top Australian firms ill-equipped for business in Asia

Report finds majority of top A…

AusBN - A report by think tank Asialink has found that a large majority of ...

Healthscope sells Australian pathology operations

AusBN – Crescent Capital Partners has acquired Healthscope’s Australian pathology operations for A$105 million.

Over 500 collection centres and 30 laboratories in Victoria and the Northern Territory will now be operated by Crescent Capital.

Healthscope will also transfer six of its skin clinics to Crescent and the proceeds from the sale will be used to fund its expansion plans at major hospital sites.

Healthscope CEO Robert Cooke said: “Our Australian pathology operations are non-core, have been operating in challenging market conditions for a number of years and their underlying earnings contribution to the group is limited.

 “We remain committed to our international pathology operations, which have consistently performed well over time.” 

@AusBNOnline

This Month's Issue

AusBN Vol3 Iss1

Subscribe

rgn web banner

abn web banner